RBP4 and metabolic dysfunction-associated steatotic liver disease: To our knowledge, this is the first study to examine the relationship between circulating RBP4 and body fat composition, including hepatic fat content, visceral and subcutaneous abdominal fat in a cohort of Chinese NAFLD patients without known diabetes.